Seek medical help if symptoms are severe, persistent, or include signs like intense abdominal pain or fainting
En el programa de estudios de fase 3 ATTAIN, dirigido a personas con obesidad, los participantes que recibieron la dosis ms alta perdieron en promedio 12.4% de su peso corporal , de acuerdo con los resultados difundidos por la compaa
[3] In SUSTAIN trials, injectable semaglutide at 1.0 mg weekly delivered about 4.7 kg (10.4 lbs.) of weight loss versus 0.9 kg (2 lbs.) on placebo
Hydroxocobalamin 20 mg/ml Injection Solution is a potent formulation used in the treatment of specific types of anemia, particularly those caused by folate deficiency such as megaloblastic anemia
A randomized, double-blind, placebo-controlled phase II study (MOT114479) to evaluate the safety and efficacy and dose response of 28 days of orally administered camicinal, a motilin receptor agonist, in diabetics with gastroparesis